Vasily, Thank you very much, for the 20 twenty e-mail List:))
Yeah, the 20 twenty have 60% of the total Vote, and most of them would have paid much higher prices for their shares....
So, it's almost inconceivable to even think , that they would accept anything, but a logical share Price , say, nothing below 20 cents AT LEAST, (at the stage where we are at the moment). The Same thing applies to the rest of us, who have not made it to the top twenty...No one would accept any Take Over Bid below a Fair Share Price, considering the Immense Potential PAB Antibody Cancer Therapy has.....
Furniture, thanks for your reply, clarifying what one may perceive (wrongly) as information, emanating from "certain" Sources that would be interested in spreading such rumours....
Cheers:))
PS. The Worst Month of the Year (June) for the Small End of the Market is over....And.... The Beginning of the New Financial Year, coincides with the Imminent (we certainly hope so, Days away???)Announcement of the Third Cohort Results, which could be above expectations.....
- Forums
- ASX - By Stock
- overhang
Vasily, Thank you very much, for the 20 twenty e-mail...
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.6¢ | $14.17K | 2.087M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 132483 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1945092 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 132483 | 0.007 |
16 | 5482389 | 0.006 |
16 | 7315158 | 0.005 |
9 | 5566451 | 0.004 |
7 | 6399016 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 1945092 | 5 |
0.009 | 1133332 | 2 |
0.010 | 1412000 | 3 |
0.011 | 1080000 | 2 |
0.012 | 1558283 | 5 |
Last trade - 15.48pm 29/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |